ÇAM, F. And Celiker, H. 2024. Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study. EYE , vol.38, no.5 , 893-901.

ÇAM, F., & Celiker, H., (2024). Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study. EYE , vol.38, no.5, 893-901.

ÇAM, FURKAN, And HANDE ÇELİKER ATABERK. "Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study," EYE , vol.38, no.5, 893-901, 2024

ÇAM, FURKAN And Celiker, HANDE Ç. . "Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study." EYE , vol.38, no.5, pp.893-901, 2024

ÇAM, F. And Celiker, H. (2024) . "Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study." EYE , vol.38, no.5, pp.893-901.

@article{article, author={FURKAN ÇAM And author={HANDE ÇELİKER ATABERK}, title={Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study}, journal={EYE}, year=2024, pages={893-901} }